e-learning
resources
Breathe
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lymphangioleiomyomatosis (LAM)
Source:
Breathe 2017; 13: 64-71
Journal Issue:
March
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lymphangioleiomyomatosis (LAM). Breathe 2017; 13: 64-71
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
The large airway lesions of lymphangioleiomyomatosis: Pathological and radiological analysis
What is LAM and how should it be managed?
Related content which might interest you:
Lymphangioleiomyomatosis
Source: Eur Respir J 2006; 28: 1284
Year: 2006
Lymphangioleiomyomatosis
Source: Eur Respir Mon; 2009: 46: 176–207
Year: 2009
Lymphangioleiomyomatosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008
LAM: lymphangioleiomyomatosis
Source: Breathe 2014; 10:331-332
Year: 2014
Lymphangioleiomyomatosis (LAM) initially presented as retroperitoneal tumour. Two case reports
Source: Eur Respir J 2005; 26: Suppl. 49, 83s
Year: 2005
Lymphangioleiomyomatosis – an analysis of 4 cases
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Is pulmonary rehabilitation (PR) an effective therapy in lymphangioleiomyomatosis (LAM)?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Lymphangioleiomyomatosis: what do we know and what are we looking for?
Source: Eur Respir Rev 2011; 20: 34-44
Year: 2011
Lymphangioleiomyomatosis: characteristics of 96 patients in China
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008
Lymphangioleiomyomatosis: a clinical review
Source: Breathe, 16 (2) 200007; 10.1183/20734735.0007-2020
Year: 2020
Experience with lung transplantation in lymphangioleiomyomatosis (LAM) in our center
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
Serial CT density in lymphangioleiomyomatosis (LAM)
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Differences in pulmonary function tests (PFTs) in patients with pulmonary lymphangioleiomyomatosis (LAM) and multiple benign pulmonary leiomyomatosis (MPL)
Source: Eur Respir J 2004; 24: Suppl. 48, 222s
Year: 2004
Ten-years follow-up of slowly progressive pulmonary lymphangioleiomyomatosis (PLAM)
Source: Eur Respir J 2001; 18: Suppl. 33, 219s
Year: 2001
Case report: Hermansky-Pudlak syndrome (HPS) and single lung transplantation (LUTX)
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
Early-onset therapy with sirolimus helps to improve prognosis of patients with lymphangioleiomyomatosis (LAM)
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019
Lymphangioleiomyomatosis
Source: Eur Respir J 2006; 27: 1056-1065
Year: 2006
Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
Source: ERJ Open Res, 4 (1) 00121-2017; 10.1183/23120541.00121-2017
Year: 2018
Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM)
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept